SPY313.34+2.82 0.91%
DIA259.43+2.12 0.82%
IXIC10,252.41+97.78 0.96%

CASI Pharmaceuticals Q3 EPS $(0.1), Same YoY

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.1) per share. This is unchanged from the same period last year.

Benzinga · -

CASI Pharmaceuticals (NASDAQ:CASI) reported quarterly losses of $(0.1) per share. This is unchanged from the same period last year.